Five percent of patients given 20 mg of Acomplia (rimonabant) required anti-depressant medication compared to 3 percent of those given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark.
This is despite the fact that “[all of] the included trials excluded patients with existing depression, or those with a history [of depression],” Astrup noted.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.